Lightwave's system combines multiple channels on demand to give surgeons a clear view of the margins between cancer and healthy tissue
source: Avelas Biosciences
source: OnTarget Labs
Multispectral imaging is the new paradigm for safe and accurate imaging of cancer in surgical planning and guidance during surgery. Cancer Imaging Solutions (CIS) has pioneered the most sensitive detector system with eight or more concurrent imaging channels and the broadest wavelength spectrum in the industry.
CIS' optical sensor system has achieved an unprecedented level of sensitivity where it can detect and differentiate cancer cells and tumors from normal cells and tissue without the harmful ionizing radiation from X-Rays nor the radioactive emissions from PET scanning that damage healthy cells with their high energy levels.
CIS has advanced the sensor technology and software algorithms to make optical imaging more sensitive and specific for cancer detection. The optical imaging modality can now be used for a) early detection for cancer screening, b) detecting metastasis and single cell invasion to surrounding tissue, c) image-guided surgery to assure complete resection of all cancer cells, and d) follow-up screenings to monitor the efficacy of therapies and the state of remission.
Optical imaging has the potential to transform how we detect and treat cancer with safe, low cost, regular screening. Early and accurate detection and complete surgical removal can change a diagnosis of cancer from a life-threatening disease to a short-term treatment with full recovery.
Portable and low-cost optical sensors will make it possible to provide cancer screening services to everyone, particularly for underserved and disadvantaged populations, thereby reducing the burden of cancer on all of society.
ADVANCED MEDICAL IMAGING TECHNOLOGY - CUSTOMIZABLE FOR THE TYPE OF CANCER
The optical sensor technology is small, portable and customizable for different settings and types of cancer. Different screening procedures call for different sensor configurations and functions: eight (8) sensors for surgical applications, sixteen (16) sensors for breast cancer imaging, etc.. The systems can be adapted to work in combination with other imaging modalities like ultrasound and MRI to impove the diagnostic sensitivity and specificity of the combined imaging results.
To eliminate late stage cancer through early detection for as many people in the world as we can. To develop and deploy optical sensor technology and advanced analytical software for cancer detection and imaging.
Our team includes:
Member of NVIDIA Inception Program
Member of NVIDIA Developer Program
~~~~~~~~~~~~~~~
Member of IBM PartnerWorld
~~~~~~~~~~~~~~~
Foundation for Early Detection of Disease
Mr. Stetson is the Founder of Cancer Imaging Solutions, Inc., and is driven by his personal motivation to beat cancer with his decades of experience in digital imaging and data analytics with satellite imagery. In June of 2022 Mr. Stetson completed an 18-month Cooperative R&D Agreement (CRADA) with the National Institute of Biomedical Ima
Mr. Stetson is the Founder of Cancer Imaging Solutions, Inc., and is driven by his personal motivation to beat cancer with his decades of experience in digital imaging and data analytics with satellite imagery. In June of 2022 Mr. Stetson completed an 18-month Cooperative R&D Agreement (CRADA) with the National Institute of Biomedical Imaging and Bioengineering at NIH involving his imaging technology. His experience in the fields of automated image analysis and artificial intelligence began in the 1980's. Over the years, NASA, DoD and several other federal agencies, foreign governments and private corporations have relied upon Mr. Stetson's expertise to develop a variety of imaging solutions. Now, he is applying his knowledge to beating cancer!
Leading up to his role at Cancer Imaging Solutions, Mr. Jackson has been the Managing Director of ETEC Consulting Group, a consultancy specializing in Quality and Risk Management Systems, and engineering and business process improvement for Fortune 500 clients worldwide. His knowledge of QM and RM protocols are essential to the design an
Leading up to his role at Cancer Imaging Solutions, Mr. Jackson has been the Managing Director of ETEC Consulting Group, a consultancy specializing in Quality and Risk Management Systems, and engineering and business process improvement for Fortune 500 clients worldwide. His knowledge of QM and RM protocols are essential to the design and implementation of CIS initial imaging systems and the future regulatory approval of CIS' diagnostic capabilities with AI data analytics.
Dr. Kraft earned his M.D. from Georgetown University Medical School. He then spent two decades serving as Chairman and Vice- Chairman of two community hospital departments. Dr. Kraft has had a dual career, medicine and highly scalable software. He has also been a CEO and a C-level executive at multiple software companies and filed numerou
Dr. Kraft earned his M.D. from Georgetown University Medical School. He then spent two decades serving as Chairman and Vice- Chairman of two community hospital departments. Dr. Kraft has had a dual career, medicine and highly scalable software. He has also been a CEO and a C-level executive at multiple software companies and filed numerous patents. Dr. Kraft guides the team with his knowledge of the medical field and software development.
Mr Riker has over two decades experience in business strategy, as former CEO at Capgemini Telecom, Media, Networks, and currently as Senior Professor of the Blue Ocean Academy and Managing Director of the Blue Ocean Strategy Initiative Centre. Mr Riker has worked to shape and execute high-growth strategies across numerous industries, geo
Mr Riker has over two decades experience in business strategy, as former CEO at Capgemini Telecom, Media, Networks, and currently as Senior Professor of the Blue Ocean Academy and Managing Director of the Blue Ocean Strategy Initiative Centre. Mr Riker has worked to shape and execute high-growth strategies across numerous industries, geographies and product markets. Mr. Riker serves as the Director of Business Strategy to optimize the market value of Cancer Imaging Solutions' technology.
Support early cancer detection through tax deductible contributions